Last update 20 Mar 2025

Isophane Protamine Recombinant Human Insulin Injection(Shenzhen Kexing Biotech Co. Ltd.)

Overview

Basic Info

Drug Type
Biosimilar, Hormone
Synonyms
Isophane Protamine Recombinant Human Insulin, 精蛋白重组人胰岛素注射液（深圳科兴）, 苏泌啉恩
Target
INSR
Action
agonists
Mechanism
INSR agonists(Insulin receptor agonists)
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication
Diabetes Mellitus
Inactive Indication-
Originator Organization
Shenzhen Kexing Biotech Co. Ltd.Shenzhen Kexing Biotech Co. Ltd.
Active Organization
Beijing Yadong Biopharmaceutical (Anguo) Co., Ltd.Beijing Yadong Biopharmaceutical (Anguo) Co., Ltd.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
China (24 Feb 2003),
Diabetes Mellitus
Regulation-
Login to view timeline

Structure/Sequence

Related

100 Clinical Results associated with Isophane Protamine Recombinant Human Insulin Injection(Shenzhen Kexing Biotech Co. Ltd.)
Login to view more data
100 Translational Medicine associated with Isophane Protamine Recombinant Human Insulin Injection(Shenzhen Kexing Biotech Co. Ltd.)
Login to view more data
100 Patents (Medical) associated with Isophane Protamine Recombinant Human Insulin Injection(Shenzhen Kexing Biotech Co. Ltd.)
Login to view more data
100 Deals associated with Isophane Protamine Recombinant Human Insulin Injection(Shenzhen Kexing Biotech Co. Ltd.)
Login to view more data

External Link

KEGGWikiATCDrug Bank
--
A10AF01A10AD01A10AC01A10AB01A10AE01
-

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetes Mellitus
China
Beijing Yadong Biopharmaceutical (Anguo) Co., Ltd.Beijing Yadong Biopharmaceutical (Anguo) Co., Ltd.
24 Feb 2003
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free